Lake Bleu Capital
Private equityHong Kong · Seed–Growth
Find your way into Lake Bleu Capital
What they invest in
from 2 of 2 portfolio companiesBiotech ×2AI & Machine Learning ×1Digital Health ×1Healthtech ×1Medical Devices ×1
HQs:Germany×1
Investments · 2 tracked
founders shown can be your intro pathBy year:2021 · 12019 · 12 dated
Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development.
AI & Machine LearningBiotechDigital HealthHealthtechHong Kong
Alex Zavoronkov(Director)Alex Zhavoronkov(Founder & CEO)inAlex Aliper(President)inFeng Ren(Chief Scientific Officer, Executive Director & Co-CEO)in
BoardNisa Leung(Director)Lennart Lee(Director)
Co-investorsLilly Asia VenturesOrbiMedQiming Venture PartnersWarburg PincusBaidu VenturesEight Roads Ventures+9 more
Singleron Biotechnologies develops single-cell and single-nucleus sequencing kits and solutions for transcriptome analysis of biological samples.
BiotechMedical DevicesCologne, DE
Co-investorsARCH Venture PartnersLAVLilly Asia VenturesMSA CapitalSBCVCSherpa Healthcare Partners
Portfolio news
latest coverage across their companies
Frequently asked questions
- What stage does Lake Bleu Capital invest at?
- Lake Bleu Capital invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Lake Bleu Capital focus on?
- Lake Bleu Capital focuses on Biotech, Healthtech.
- Where is Lake Bleu Capital located?
- Lake Bleu Capital is headquartered in Hong Kong, HK.
Similar investors
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Legendary Ventures is a venture capital firm focused on consumer, retail, and technology (CRT) companies, combining the expertise of venture capitalists and retail executives to support portfolio companies and identify acquisition partners.
Kaiser Permanente Ventures is the corporate venture capital arm investing in healthcare companies that address real needs and deliver value for patients, providers, healthcare delivery systems, and communities.
Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.
Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.